Clinical trial
Multicentric Retrospective Case Control Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
NCT01201655 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric Retrospective Case Control Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
- Lead sponsor
- Xijing Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 5,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, hepatocellular, laparotomy, liver cirrhosis, splenomegaly